Introduction to Cortagen 20mg
Cortagen is a synthetic short-chain peptide investigated in preclinical research for its potential role in supporting central nervous system structure and signaling pathways. Structurally related to proteins found in neural tissue, Cortagen is used in laboratory settings to study cellular mechanisms related to cognitive processes and neuroprotection. The 20mg format is standardized for consistent use in controlled experiments.
Key Research Areas
Ongoing in vitro and in vivo studies involving Cortagen focus on:
Cognitive Pathway Modeling: Examining peptide influence on memory-related gene expression and synaptic activity in animal models.
Neuroprotective Response Research: Investigating potential modulation of oxidative stress and inflammation in neuronal tissues.
Peptide Signaling Studies: Exploring interactions between Cortagen and endogenous neuropeptides that regulate neural development and plasticity.
Brain Tissue Repair Models: Evaluating structural support of neural tissue under induced injury or degenerative conditions.
For Laboratory Research Use Only – Not for Human or Veterinary Use
Cortagen 20mg is not approved by the FDA for therapeutic or diagnostic purposes. Use is limited to non-clinical, academic, and preclinical research.
Certificate of Analysis
| Property | Description |
|---|---|
| Chemical Sequence | Ala-Glu-Asp-Gly |
| CAS | 120924-09-0 |
| Molecular Formula | C16H23N5O7 |
| Molecular Weight | Approximately 401.38 g/mol |
| Appearance | White Lyophilized Powder |
Research Use Only:
Cortagen 20mg is intended strictly for in vitro testing and laboratory experimentation. It is not intended for human or animal medical use. It is not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.
